United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2020_register
executive
2020-11-10
article
Special Considerations, Incentives, and Programs To Support the Approval of New Animal Drugs for Minor Uses and for Minor Species; Draft Guidance for Industry; Availability; Extension of Comment Period
Notices
D09002ee1bdb33d80
D09002ee1bdb33dd9
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA or the Agency) is extending the comment period for the notice of availability that appeared in the Federal Register of July 15, 2020. In that notice, FDA requested comments on draft guidance for industry (GFI) #61 entitled ``Special Considerations, Incentives, and Programs to Support the Approval of New Animal Drugs for Minor Uses and for Minor Species.'' FDA is taking this action in response to a request for an extension to allow interested persons additional time to submit comments.
85 FR 71659
https://www.govinfo.gov/app/details/FR-2020-11-10/2020-24970
2020-24970
fr10no20-59
4164-01-P
Docket No. FDA-1997-D-0444
https://www.govinfo.gov/app/details/FR-2020-11-10/2020-24970
https://www.govinfo.gov/content/pkg/FR-2020-11-10/html/2020-24970.htm
https://www.govinfo.gov/content/pkg/FR-2020-11-10/pdf/2020-24970.pdf
2 p.
71659
71660
85 FR 71659
Special Considerations, Incentives, and Programs To Support the Approval of New Animal Drugs for Minor Uses and for Minor Species; Draft Guidance for Industry; Availability; Extension of Comment Period; Federal Register Vol. 85, Issue
NOTICE
2020-24970
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
2021-01-11
Docket No. FDA-1997-D-0444
4164-01-P
2020-24970
Notice of availability; extension of comment period.
The Food and Drug Administration (FDA or the Agency) is extending the comment period for the notice of availability that appeared in the Federal Register of July 15, 2020. In that notice, FDA requested comments on draft guidance for industry (GFI) #61 entitled ``Special Considerations, Incentives, and Programs to Support the Approval of New Animal Drugs for Minor Uses and for Minor Species.'' FDA is taking this action in response to a request for an extension to allow interested persons additional time to submit comments.
FDA is extending the comment period announced in the notice of availability published July 15, 2020 (85 FR 42876). Submit either electronic or written comments by January 11, 2021, to ensure that the Agency considers your comments on this draft guidance before it begins work on the final version of the guidance.
Margaret Oeller, Center for Veterinary Medicine (HFV-50), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 240-402-0566, margaret.oeller@fda.hhs.gov.
Guidance:
Special Considerations, Incentives, and Programs To Support the Approval of New Animal Drugs for Minor Uses and for Minor Species,
margaret.oeller@fda.hhs.gov
https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf
https://www.regulations.gov
Federal Register
Vol. 85, no. 218
Office of the Federal Register, National Archives and Records Administration
2020-11-10
continuing
daily
deposited
born digital
293 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2020-11-10
P0b002ee1a940dfc3
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr10no20
https://www.govinfo.gov/app/details/FR-2020-11-10
https://www.govinfo.gov/content/pkg/FR-2020-11-10/pdf/FR-2020-11-10.pdf
https://www.govinfo.gov/content/pkg/FR-2020-11-10/xml/FR-2020-11-10.xml
fdlp
71529
71813
DGPO
2020-11-10
2023-04-27
FR-2020-11-10
machine generated
eng
FR
FR-2020-11-10
85
218